DE87932C - - Google Patents
Info
- Publication number
- DE87932C DE87932C DENDAT87932D DE87932DA DE87932C DE 87932 C DE87932 C DE 87932C DE NDAT87932 D DENDAT87932 D DE NDAT87932D DE 87932D A DE87932D A DE 87932DA DE 87932 C DE87932 C DE 87932C
- Authority
- DE
- Germany
- Prior art keywords
- oxime
- chloral
- chloralacetophenone
- effect
- koenigs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 claims description 5
- JHNRZXQVBKRYKN-VQHVLOKHSA-N (ne)-n-(1-phenylethylidene)hydroxylamine Chemical compound O\N=C(/C)C1=CC=CC=C1 JHNRZXQVBKRYKN-VQHVLOKHSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- -1 chloral acetophenone oxime Chemical compound 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 150000002923 oximes Chemical class 0.000 description 13
- 230000000694 effects Effects 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 4
- 229960002327 chloral hydrate Drugs 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000003544 oxime group Chemical group 0.000 description 3
- GXFZCDMWGMFGFL-KKXMJGKMSA-N (+)-Tubocurarine chloride hydrochloride Chemical compound [Cl-].[Cl-].C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CC[NH+]3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 GXFZCDMWGMFGFL-KKXMJGKMSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000008709 Curare Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- BVHZGCQCZRDLJR-UHFFFAOYSA-N n-(2,2,2-trichloroethylidene)hydroxylamine Chemical class ON=CC(Cl)(Cl)Cl BVHZGCQCZRDLJR-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241001111317 Chondrodendron tomentosum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 208000016254 weariness Diseases 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE87932C true DE87932C (enExample) |
Family
ID=359867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT87932D Active DE87932C (enExample) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE87932C (enExample) |
-
0
- DE DENDAT87932D patent/DE87932C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD158773A5 (de) | Verfahren zur herstellung neuer glycerol-deri vate | |
| AT509501B1 (de) | Pflanzenschutzmittel | |
| DE1645971C3 (de) | (lndazol-3-yl)-oxyessigsäurederivate, Verfahren zu ihrer Herstellung und Mittel mit entzündungshemmender Wirkung | |
| DD264913B3 (de) | Verfahren zur herstellung eines kristallinen produktes | |
| DE2807643C2 (enExample) | ||
| DE2504045C3 (de) | 16,17 Dihydro-apovincaminsäure-2hydroxypropylester, deren Salze, Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE87932C (enExample) | ||
| DE3226225C2 (enExample) | ||
| DE2019504C3 (de) | Oxim-N-acylcarbamate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Schädlingsbekämpfung | |
| DE69207893T2 (de) | Pyrethroidhaltige zusammenstellung | |
| DE3115881A1 (de) | Verfahren zur herstellung von cyclopropancarbonsaeureester-derivaten | |
| DE2748291B2 (de) | Substituierte 13-Benzodioxan-4one und Verfahren zu ihrer Herstellung sowie Verwendung dieser Verbindungen bei der Bekämpfung von Entzündungen | |
| EP0053756B1 (de) | 2,6-Diethyl-3,5-dimethyl-2,3-dihydro-4H-pyran, Verfahren zu seiner Herstellung und seine Verwendung zur Früherkennung, Lokalisierung und Bekämpfung von Lasioderma serricorne F | |
| DE2817558C2 (de) | Antitumormittel mit einem Gehalt an Derivaten von Trans-4-(aminomethyl)cyclohexan-1-carbonsäure | |
| DE2624177A1 (de) | Verfahren zur herstellung von m-benzoylhydratropsaeure | |
| DE2614797C3 (de) | Aromakomposition bzw. Verwendung von 2-Phenyl-3-(fur-2-yl)-prop-2-en-l-al als Aroma- bzw. Geschmackstoff | |
| DE2321198C3 (de) | Chlorderivate von Methylisopropylphenolen und diese enthaltende Arzneimittel | |
| DE1443408C (de) | 17,20 Dimethyl 18 nor 17alpha-pregn 5,13 dien 3beta, 16alpha, 20 triol, dessen 3 Mono- und 3,16 Diacetat und Verfahren zu deren Herstellung | |
| DE1193938B (de) | Verfahren zur Herstellung des Racemats und der Stereoisomeren einschliesslich des Mesoisomeren von Butan-1, 2, 3, 4-tetrol-1, 4-di-(methansulfonat) | |
| DE194810C (enExample) | ||
| DE138100C (enExample) | ||
| DE1468554C (de) | 20 beta tert Amino 3 alpha hydroxy (bzw acyloxy) 5 beta pregnane bzw de ren Salze sowie Verfahren zu ihrer Her stellung | |
| DE164884C (enExample) | ||
| AT216687B (de) | Verfahren zur Herstellung von Testosteronderivaten | |
| DE2321198B2 (de) | Chlorderivate von Methylisopropylphenolen und diese enthaltende Arzneimittel |